Logo

Evotec

Evotec, Hannover Medical School Partner on Multiomic Autoimmune Disease Patient Database

The German medical school will analyze samples from hundreds of Sjögren's and systemic lupus erythematosus patients in search of new treatment pathways.

Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development

The companies will work together to identify and develop small molecule drugs against RNA targets that fit within Takeda's disease areas of focus.

Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery

The deal comes on the heels of a colorectal cancer-focused drug-discovery alliance that the German companies formed in early 2019.

Evotec, Celmatix Partner on Women's Reproductive Health Drug Discovery

About a year ago, New York City-based Celmatix launched a division to discover therapeutics for women's health indications including reproductive disorders.

Evotec Acquires iPSC Drug-Discovery Assets From Ncardia

The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing product business around iPSC-derived cells.

Apr 11, 2019

Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery

Sep 6, 2018

Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery

Aug 27, 2018

Centogene, Evotec Forge Drug-Discovery Alliance

May 2, 2018

Evotec Licenses CRISPR-Cas9 Technology From ERS

Dec 4, 2017

Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling

Aug 4, 2017

In Brief This Week: Thermo Fisher, Grifols, MDxHealth, Exosome Diagnostics, and More

Nov 30, 2016

Evotec Inks Deal to Offer Merck KGaA Gene Editing, Silencing Technologies

Jul 6, 2016

Evotec Licenses CRISPR Tech From Broad Institute, Harvard

Sep 11, 2014

CHDI Extends Evotec Huntington's Collaboration Through 2017

Apr 25, 2014

Evotec-Roche Deal Indicates Adoption of Mass Spec, Hi-Res Instrumentation for Clinical Protein Quant
Premium

Sep 12, 2013

Evotec, HSCI Ink ALS Deal

Sep 6, 2013

String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms
Premium

Aug 21, 2013

Evotec, Jain Foundation Expand Muscular Dystrophy Collaboration

Jul 9, 2013

Evotec, Dow AgroSciences Enter Proteomics Service Deal

Jan 4, 2013

Evotec Inks Deal with Apeiron to Use Chemical Proteomics in Cancer Drug Development
Premium

Jan 3, 2013

Evotec Buys Cell-based Reagents Firm for up to $2.9M

Sep 21, 2012

In Brief This Week: Roche; Life Technologies; Trovagene, Strand; Fluidigm; Wellington Partners; Proteros, UCB; Evotec

May 18, 2012

GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
Premium

Apr 20, 2012

UNC Team Takes Proteomic Approach to Study Drug Resistance in Triple-Negative Breast Cancer
Premium

Jul 1, 2011

Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.